East Genomics

Mobile menu open

Consolidating rare disease tests from Nottingham

From 23rd November, our Cambridge lab will take on the processing of several rare disease tests from Nottingham. There is no need to change how tests are requested.

Tests should still be ordered and samples sent via our Nottingham lab. Please place orders using our using our rare disease non-WGS order form. Tests will then be sent onward to Cambridge. Reports will be returned directly from the Cambridge lab but there will be no change to the results included.

You may be affected by this change if you are a specialist in:

  • Clinical genetics
  • Endocrinology
  • Gynaecology
  • Neonatology
  • Neurology
  • Paediatrics – including community paediatrics
  • Psychiatry

Affected tests

Diagnostic tests moving to Cambridge are:

Clinical indication Test code Referring specialisms Notes
Clinical indication Huntington
disease
Test code R68.1 Referring specialisms Clinical genetics, Neurology, Psychiatry Notes
Clinical indication Hereditary neuropathy - PMP22 copy number Test code R77.1 Referring specialisms Clinical genetics, Neurology, Paediatrics Notes The methodology used for this test will change to microarray but results reported will be unaffected.
Clinical indication Premature ovarian insufficiency (FMR1 testing) Test code R402.1 Referring specialisms Clinical genetics, Endocrinology, Gynaecology Notes Also includes confirmation tests for other FMR1-related conditions Fragile X and FXTAS
Clinical indication Myotonic dystrophy type 1 Test code R72.1 Referring specialisms Clinical genetics, Neurology Notes
Clinical indication Duchenne or Becker muscular dystrophy Test code R73.2 Referring specialisms Clinical genetics, Community Paediatrics, Neurology, Paediatrics Notes R73.1 tests are already run at Cambridge
Clinical indication Familial testing for the above conditions, via:
* Diagnostic testing for known variant(s)
* Predictive testing for known familial variant(s)
* Carrier testing for known familial variant(s)
Test code R240.1, R242.1, R244.1 Referring specialisms Clinical genetics Notes

Further tests are expected to move to Cambridge early in 2027. These include:

  • Angelman syndrome (R47.1)
  • Prader-Willi syndrome (R48.1)

Tests are being consolidated to Cambridge to ensure best use of available resources within the region and to avoid unnecessary duplication. The change is expected to improve overall efficiency helping to ensure a more reliable and consistent regional genomic testing service.

Please contact the Cambridge lab with any questions about this change: cuh.geneticslaboratories@nhs.net